Glorious Trading Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 0.28 Cr
as on 31-07-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.00 Cr
as on 31-07-2024
- Revenue 76.26%
(FY 2023)
- Profit -75.85%
(FY 2023)
- Ebitda -161.40%
(FY 2023)
- Net Worth -13.08%
(FY 2023)
- Total Assets 0.49%
(FY 2023)
About Glorious Trading
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.28 Cr.
The company has closed loans amounting to ₹10.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramesh Jatia, Smita Rameshkumar, and Atishay Ramesh serve as directors at the Company.
- CIN/LLPIN
U51109GJ2007PTC050708
- Company No.
050708
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Glorious Trading?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramesh Jatia | Director | 01-May-2007 | Current |
Smita Rameshkumar | Director | 01-May-2007 | Current |
Atishay Ramesh | Director | 04-Aug-2017 | Current |
Financial Performance and Corporate Structure Insights of Glorious Trading.
Glorious Trading Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 76.26% increase. The company also saw a substantial fall in profitability, with a 75.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Glorious Trading?
In 2023, Glorious Trading had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Renown Pharmaceuticals Private Limited
Active 19 years 2 monthsRamesh Jatia, Smita Rameshkumar and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 08 Sep 2007 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Glorious Trading?
Glorious Trading has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glorious Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glorious Trading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.